Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis

American Journal of Pathology

Volumn 162, Issue 5, 2003, Pages 1549-1557

  Seemayer, Christian A ^a,c   Kuchen, Stefan ^a   Kuenzler, Peter ^a   Řihošková, Veronika ^a   Rethage, Janine ^a   Aicher, Wilhelm K ^b   Michel, Beat A ^a   Gay, Renate E ^a   Kyburz, Diego ^a   Neidhart, Michel ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Center of Experimental Rheumatology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CD40 ANTIGEN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE 14; THY 1 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCID MOUSE; SKIN FIBROBLAST; SYNOVIUM;

EID: 0037407733     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64289-7     Document Type: Article

References (35)

1. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993, 52(Suppl 1):S39-S47
2. Muller-Ladner U, Gay RE, Gay S: Activation of synoviocytes. Curr Opin Rheumatol 2000, 12:186-194
3. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996, 149:1607-1615
4. Nykanen P, Bergroth V, Raunio P, Nordstrom D, Konttinen YT: Phenotypic characterization of 3H-thymidine incorporating cells in rheumatoid arthritis synovial membrane. Rheumatol Int 1986, 6:269-271
5. Konttinen YT, Nykanen P, Nordstrom D, Saari H, Sandelin J, Santavirta S, Kouri T: DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol 1989, 16:339-345
6. Mohr W, Hummler N, Pelster B, Wessinghage D: Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int 1986, 6:127-132
7. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT: Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum 1994, 37:212-220
8. Yamasaki S, Kawakami A, Nakashima T, Nakamura H, Kamachi M, Honda S, Hirai Y, Hida A, Ida H, Migita K, Kawabe Y, Koji T, Furuichi I, Aoyagi T, Eguchi K: Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells. Ann Rheum Dis 2001, 60:678-684
9. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000, 182:311-322
10. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL: Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989, 83:1267-1276
11. Fassbender HG, Simmling-Annefeld M: The potential aggressiveness of synovial tissue in rheumatoid arthritis. J Pathol 1983, 139:399-406
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TAJ, Mitchell DM, Newstadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324
13. Haas C, Aicher WK, Dinkel A, Peter HH, Eibel H: Characterization of SV40T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatol Int 1997, 16:241-247
14. McBride S, Heenan M, Clynes M: Cloning animal cells. Animal Cell Culture techniques. Edited by Clynes M. Heidelberg, Berlin, Springer, 1998, pp 3-12
15. Pap T, van der Laan WH, Aupperle KR, Gay RE, Verheijen JH, Firestein GS, Gay S, Neidhart M: Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum 2000, 43:2531-2536
16. Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T, Kirchner T: The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 2001, 159:1613-1617
17. Khoshyomn S, Lew S, DeMattia J, Singer EB, Penar PL: Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. J Neurooncol 1999, 45:111-116
18. Youn J, Kim HY, Park JH, Hwang SH, Lee SY, Cho CS, Lee SK: Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 2002, 83:85-93
19. Ohshima S, Mima T, Sasai M, Nishioka K, Shimizu M, Murata N, Yoshikawa H, Nakanishi K, Suemura M, McCloskey RV, Kishimoto T, Saeki Y: Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA. Cytokine 2000, 12:281-288
20. Feldmann M: Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002, 2:364-371
21. Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T: The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera. Rheumatology (Oxford) 2002, 41:329-337
22. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K: Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996, 55:442-449
23. Schedel J, Gay RE, Kuenzler P, Seemayer C, Simmen B, Michel BA, Gay S: FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rhaumatoid arthritis. Arthritis Rheum 2002, 46:1512-1518
24. Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Muller-Ladner U, Gay RE, Gay S: Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 2000, 43:599-607
25. Seemayer CA, Distler O, Kuchen S, Muller-Ladner U, Michel BA, Neidhart M, Gay RE, Gay S: Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts. Z Rheumatol 2001, 60:309-318.
26. Lemaire R, Flipo RM, Monte D, Dupressoir T, Duquesnoy B, Cesbron JY, Janin A, Capron A, Lafyatis R: Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice. J Rheumatol 1994, 21:1409-1419
27. Logan SK, Hansell EJ, Damsky CH, Werb Z: T-antigen inhibits metalloproteinase expression and invasion in human placental cells transformed with temperature-sensitive simian virus 40. Matrix Biol 1996, 15:81-89
28. Hou WS, Li Z, Gordon RE, Chan K, Klein MJ, Levy R, Keysser M, Keyszer G, Bromme D: Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol 2001, 159:2167-2177
29. Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Bromme D: Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 2002, 46:663-674
30. Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S: Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 2000, 43:1226-1232
31. Yamanaka H, Makino K, Takizawa M, Nakamura H, Fujimoto N, Moriya H, Nemori R, Sato H, Seiki M, Okada Y: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium. Lab Invest 2000, 80:677-687
32. Goto M, Okamoto M, Sasano M, Nishizawa K, Aotsuka S, Yamaguchi N, Obinata M, Ikeda K: Functional characterization of SV40-transformed adherent synovial cells from rheumatoid arthritis. Clin Exp Immunol 1991, 86:387-392
33. Miyazawa K, Mori A, Okudaira H: Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem (Tokyo) 1998, 124:1153-1162
34. Zhang HG, Blackburn Jr WD, Minghetti PP: Characterization of a SV40-transformed rheumatoid synovial fibroblast cell line which retains genotypic expression patterns a model for evaluation of anti-arthritic agents. In Vitro Cell Dev Biol Anim 1997, 33:37-41
35. Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M. Firestein GS: Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 1998, 152:1091-1098